First-Ever Human Trial of DNA-Based Immunotherapy Delivered Using ... WELT ONLINE, Germany - The paper concluded: "This first human trial, to our knowledge, of gene transfer utilizing in vivo DNA electroporation in metastatic melanoma showed that it ... Inovio Biomedical Says Final Results of Phase I Study Show Safe ...

Later On: Non- melanoma skin cancer can forecast others Winston-Salem Journal, NC - This study: It analyzed data on 19174 people age 25 and older, 769 of whom had received a diagnosis of non- melanoma skin cancer (either basal cell or ...

Patients presenting to skin clinic earlier than to other hospitals Irish Times, Ireland - Dr Bourke said the melanoma clinic, which was established at the South Infirmary Victoria in 2003, carried out a major comparative study of trends in ...

Reflectance Confocal Microscopy for Melanoma and Melanocytic ... Medscape - Disclosure: Charles P. Vega, MD, FAAFP, has disclosed that he has served as an advisor or consultant to Novartis, Inc. Disclosure: Elisa Manzotti has ...

Spot the deadly dot MyTown Bay of Plenty, New Zealand - About a month ago, the 31-year-old was diagnosed with melanoma , after a freckle on his lower thigh changed colour a few months after he returned to New ...

Banc of America skeptical on Synta drug Forbes, NY - He has doubts about the company's developing cancer drug elesclomol and whether it will make it past a late-stage study of patients with metastatic melanoma ...

Marshall Edwards, Inc. Files IND Application for Triphendiol MarketWatch - ... for use in conjunction with standard chemotoxic anti-cancer drugs for the treatment of late stage pancreatic cancer, cholangiocarcinoma, and melanoma . ...

Understanding Why Melanoma Survives Ivanhoe, FL - Their findings could help doctors design new strategies to prevent malignant melanoma . The process of tanning involves synthesis of the pigment melanin by ...

Melanoma cases likely to decline Stuff.co.nz, New Zealand - ... caused by clear skies and bright sunshine kill between 250 and 300 Kiwis a year, giving New Zealand the highest death rate from melanoma in the world. ... Warning over summer sun

Enrollment in Provectus' Phase 2 Melanoma Clinical Trial Reaches ... MarketWatch - a development-stage oncology and dermatology biopharmaceutical company, announced today that the first fifty percent (40 of 80) of melanoma subjects have ... Enrollment in Provectus' Phase 2 Melanoma Clinical Trial Reaches ...